Becton Dickinson (BDX) Deferred Taxes (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Deferred Taxes of -$73.0 million for Q1 2026, up 32.41% year-over-year from -$55.1 million in Q1 2025, and down 351.72% quarter-over-quarter from $29.0 million in Q4 2025.
Becton Dickinson (BDX) Deferred Taxes (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Deferred Taxes for 18 consecutive years, with -$73.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes rose 32.41% year-over-year to -$73.0 million; the TTM figure through Mar 2026 stood at -$259.0 million (up 19.31% YoY), while the FY2025 annual figure was -$474.0 million, down 124.64% from the prior year.
- Deferred Taxes retreated to -$73.0 million in Q1 2026 per BDX's latest filing, from $29.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $88.0 million in Q3 2024 and bottomed at -$219.0 million in Q3 2025.
- Historically, Deferred Taxes has averaged -$82.5 million across 5 years, with a median of -$91.0 million in 2023.
- Annual changes were most pronounced in 2023 — Deferred Taxes tumbled 1393.75% — and 2024, when it surged 144.44%.
- Becton Dickinson's Deferred Taxes stood at -$118.0 million in 2022, then gained by 22.88% to -$91.0 million in 2023, then tumbled by 65.93% to -$151.0 million in 2024, then soared by 119.21% to $29.0 million in 2025, then tumbled by 351.72% to -$73.0 million in 2026.
- Business Quant data shows BDX's Deferred Taxes at -$73.0 million in Q1 2026, $29.0 million in Q4 2025, and -$219.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | -31.00 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | -74.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | - |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 64.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | -47.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 43.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | -34.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | -9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -74.00 Mn |
| Mar 31, 2026 | -73.00 Mn |
| Dec 31, 2025 | 29.00 Mn |
| Sep 30, 2025 | -219.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | -108.00 Mn |
| Dec 31, 2024 | -151.00 Mn |
| Sep 30, 2024 | 88.00 Mn |
| Jun 30, 2024 | -150.00 Mn |
| Mar 31, 2024 | -58.00 Mn |
| Dec 31, 2023 | -91.00 Mn |
| Sep 30, 2023 | -198.00 Mn |
| Jun 30, 2023 | -99.00 Mn |
| Mar 31, 2023 | -207.00 Mn |
| Dec 31, 2022 | -118.00 Mn |
| Sep 30, 2022 | -21.00 Mn |
| Jun 30, 2022 | -46.00 Mn |
| Mar 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | -69.00 Mn |
| Sep 30, 2021 | -206.00 Mn |